156 related articles for article (PubMed ID: 11818614)
1. Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors.
Iordanescu I; Becker C; Zetter B; Dunning P; Taylor GA
Radiology; 2002 Feb; 222(2):460-7. PubMed ID: 11818614
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US.
McCarville MB; Streck CJ; Dickson PV; Li CS; Nathwani AC; Davidoff AM
Radiology; 2006 Jul; 240(1):73-81. PubMed ID: 16793972
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of quantified contrast-enhanced color and power Doppler ultrasonography for the assessment of vascularity and perfusion of naturally occurring tumors in dogs.
Schärz M; Ohlerth S; Achermann R; Gardelle O; Roos M; Saunders HM; Wergin M; Kaser-Hotz B
Am J Vet Res; 2005 Jan; 66(1):21-9. PubMed ID: 15691031
[TBL] [Abstract][Full Text] [Related]
4. Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model.
Pollard RE; Sadlowski AR; Bloch SH; Murray L; Wisner ER; Griffey S; Ferrara KW
Technol Cancer Res Treat; 2002 Dec; 1(6):459-70. PubMed ID: 12625773
[TBL] [Abstract][Full Text] [Related]
5. Sonographic depiction of changes of tumor vascularity in response to various therapies.
Niermann KJ; Fleischer AC; Donnelly EF; Schueneman AJ; Geng L; Hallahan DE
Ultrasound Q; 2005 Jun; 21(2):61-7; quiz 149, 153-4. PubMed ID: 15905816
[TBL] [Abstract][Full Text] [Related]
6. Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels.
Donnelly EF; Geng L; Wojcicki WE; Fleischer AC; Hallahan DE
Radiology; 2001 Apr; 219(1):166-70. PubMed ID: 11274552
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of protamine on human prostate carcinoma PC-3m using contrast enhanced Doppler ultrasound.
Tang J; Li S; Li J; Zhang Y; Li X; Dong B; Shi H; Zhang G
J Urol; 2003 Aug; 170(2 Pt 1):611-4. PubMed ID: 12853841
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging].
Schröder RJ; Bostanjoglo M; Hidajat N; Rademaker J; Röttgen R; Mäurer J; Felix R
Rofo; 2002 Sep; 174(9):1132-41. PubMed ID: 12221572
[TBL] [Abstract][Full Text] [Related]
9. Science to practice: Will improved assessment of response to antiangiogenic therapies be achieved with contrast-enhanced gray-scale US?
Kruskal JB
Radiology; 2006 Jul; 240(1):1-2. PubMed ID: 16793969
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of soft-tissue masses using segmented color Doppler velocity images: preliminary observations.
Adler RS; Bell DS; Bamber JC; Moskovic E; Thomas JM
AJR Am J Roentgenol; 1999 Mar; 172(3):781-8. PubMed ID: 10063882
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeted enhanced ultrasound imaging of flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model.
Xuan JW; Bygrave M; Valiyeva F; Moussa M; Izawa JI; Bauman GS; Klibanov A; Wang F; Greenberg NM; Fenster A
Mol Imaging; 2009; 8(4):209-20. PubMed ID: 19728975
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral vascularity of experimentally induced VX2 carcinoma: comparison of color Doppler sonography, power Doppler sonography, and microangiography.
Park KS; Choi BI; Won HJ; Seo JB; Kim SH; Kim TK; Han JK; Yeon KM
Invest Radiol; 1998 Jan; 33(1):39-44. PubMed ID: 9438508
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.
Kim AY; Choi BI; Kim TK; Han JK; Yun EJ; Lee KY; Han MC
Radiology; 1998 Oct; 209(1):135-40. PubMed ID: 9769824
[TBL] [Abstract][Full Text] [Related]
14. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US.
Lencioni R; Pinto F; Armillotta N; Bartolozzi C
Radiology; 1996 Nov; 201(2):353-8. PubMed ID: 8888222
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonic assessment of hepatic blood flow as a marker of mouse hepatocarcinoma.
Bonnin P; Villemain A; Vincent F; Debbabi H; Silvestre JS; Contreres JO; Levy BI; Tobelem G; Dupuy E
Ultrasound Med Biol; 2007 Apr; 33(4):561-70. PubMed ID: 17280764
[TBL] [Abstract][Full Text] [Related]
16. Quantified color Doppler sonography of tumor vascularity in an animal model.
Fleischer AC; Wojcicki WE; Donnelly EF; Pickens DR; Thirsk G; Thurman GB; Hellerqvist CG
J Ultrasound Med; 1999 Aug; 18(8):547-51. PubMed ID: 10447080
[TBL] [Abstract][Full Text] [Related]
17. Quantification of tumor vascularity and flow with amplitude color Doppler sonography in an experimental model: preliminary results.
Meyerowitz CB; Fleischer AC; Pickens DR; Thurman GB; Borowsky AD; Thirsk G; Hellerqvist CG
J Ultrasound Med; 1996 Dec; 15(12):827-33. PubMed ID: 8947858
[TBL] [Abstract][Full Text] [Related]
18. Vascular targeting tumor therapy: non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculation.
Eichhorn ME; Klotz LV; Luedemann S; Strieth S; Kleespies A; Preissler G; Lindner M; Jauch KW; Reiser MF; Clevert DA
Cancer Biol Ther; 2010 May; 9(10):794-802. PubMed ID: 20234173
[TBL] [Abstract][Full Text] [Related]
19. Feasibility study of an ultrasound contrast agent (levovist) in color Doppler imaging of liver neoplasms.
Jiang Y; Dai Q; Liu J; Zhang J; Chang X; Cai S; Tan L
Chin Med Sci J; 1999 Sep; 14(3):167-9. PubMed ID: 12903818
[TBL] [Abstract][Full Text] [Related]
20. Color Doppler flow imaging of renal disease. Value of a new intravenous contrast agent: SH U 508 A (Levovist).
Filippone A; Muzi M; Basilico R; Di Giandomenico V; Trapani AR; Bonomo L
Radiol Med; 1994 May; 87(5 Suppl 1):50-8. PubMed ID: 8209018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
